RT Journal Article SR Electronic T1 High titers of infectious SARS-CoV-2 in COVID-19 corpses JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.10.11.22280868 DO 10.1101/2022.10.11.22280868 A1 Hisako Saitoh A1 Yuko Sakai-Tagawa A1 Sayaka Nagasawa A1 Suguru Torimitsu A1 Kazumi Kubota A1 Yuichiro Hirata A1 Kiyoko Iwatsuki-Horimoto A1 Ayumi Motomura A1 Namiko Ishii A1 Keisuke Okaba A1 Kie Horioka A1 Hiroyuki Abe A1 Masako Ikemura A1 Hirofumi Rokutan A1 Munetoshi Hinata A1 Akiko Iwasaki A1 Yoichi Yasunaga A1 Makoto Nakajima A1 Rutsuko Yamaguchi A1 Shigeki Tsuneya A1 Kei Kira A1 Susumu Kobayashi A1 Go Inokuchi A1 Fumiko Chiba A1 Yumi Hoshioka A1 Aika Mori A1 Isao Yamamoto A1 Kimiko Nakagawa A1 Harutaka Katano A1 Shun Iida A1 Tadaki Suzuki A1 Shinji Akitomi A1 Iwao Hasegawa A1 Tetsuo Ushiku A1 Daisuke Yajima A1 Hirotaro Iwase A1 Yohsuke Makino A1 Yoshihiro Kawaoka YR 2022 UL http://medrxiv.org/content/early/2022/10/13/2022.10.11.22280868.abstract AB Background The prolonged presence of infectious severe acute respiratory syndrome coronavirus (SARS-CoV-2) in deceased coronavirus disease 2019 (COVID-19) patients has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses.Aim The aim of this study was to assess the level of SARS-CoV-2 infectivity in COVID-19 corpses.Methods We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation.Results Infectious virus was present in 6 of 11 (55%) cases, 4 of 11 (36%) nasopharyngeal swabs, and 9 of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units (PFU)/mL to 2.09E + 06 PFU/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days.Conclusion COVID-19 corpses may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.Competing Interest StatementThe authors have declared no competing interest.Funding Statement"Research on Evaluation of the Infectivity of coronavirus disease-2019 in Human Remains" (Project No. 20HA2008), which was funded by the Health, Labour and Welfare Administration's Research Grant for the Promotion of Emerging and Re-emerging Infectious Diseases and Immunization Policy in 2020 and 2021.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Institutional Review Boards of Chiba University Graduate School of Medicine, The University of Tokyo Graduate School of Medicine, and the Institute of Medical Science.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.